1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
| Autor: | Riedl, J.M., Posch, F., Horvath, L., Gantschnigg, A., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Stotz, M., Schaberl-Moser, R., Pichler, M., Stöger, H., Greil, R., Djanani, A., Schlick, K., Gerger, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S942-S942 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|